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INTRODUCTION 
Exsanguinating bleeding after trauma remains the leading cause of 
potentially preventable mortality. Several potential bleeding sites in blunt 
trauma are due to musculoskeletal injuries, as these are present in the 
majority of the injured. Orthopaedic trauma surgery is required in more than 
70% of trauma patients potentially adding to the pre-hospital blood loss.   
In the last decade the emphasis has shifted from uncontrolled fluid 
resuscitation, to preventing the escalation of shock and coagulopathy whilst 
achieving definitive haemostasis. Haemorrhage and resuscitation both induce 
cellular changes that can result in dysregulated immune responses and 
harmful systemic effects. The backbone of more restrictive resuscitative 
efforts remains the transfusion of packed red blood cells (PRBC). Blood is an 
expensive and finite resource and transfusion is an independent risk factor for 
systemic inflammatory response syndrome (SIRS), ICU admission, increased 
ICU length of stay, infectious complications, multiple organ failure (MOF) 
and death. PRBC transfusion has predictable and reproducible 
immunomodulatory effects. A liberal transfusion policy can introduce further 
risk to the already compromised patient. 
Fresh whole blood has been successfully used in the military setting. 
It contains all required blood components, however due to issues regarding, 
availability, screening, storage and especially safety, the use of whole blood 
in the civilian setting is unlikely. Providing other blood components in 
predefined packs to achieve a ratio resembling that of whole blood is the 
main benefit of haemostatic resuscitation. The implementation of a massive 
transfusion protocol (MTP) allows the release and administration of blood 
components, in an immediate and sustained manner, reducing bleeding 
related mortality. To characterize the effect of blood component therapy 
invariably 24 hr cumulative blood component ratios (PRBC to either fresh 
frozen plasma (FFP), cryoprecipitate (CRYO) or platelets (PLT)) and overall 
volumes of the various blood components are used to describe outcomes. As 
the majority of haemorrhagic deaths happen within the first 6 hours, survival 
bias could affect 24 hr cumulative ratios, by patients surviving eventually 
receiving higher component ratios contrary to lower ratios in non-survivors.  
Widely accepted guidelines control transfusion triggers in critical 
care, with only empirical practice influencing decision making in early 
trauma related transfusions. A clear understanding of decision making in the 
early use of PRBC in trauma resuscitation would help achieve an effective 
use of available resources, whilst simultaneously reducing the associated risk 
of transfusions. 
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AIMS 
Despite numerous advancements in the understanding of early resuscitative 
efforts in major trauma, many questions are still unanswered. In particular: 
- We only have a limited understanding of how orthopaedic injuries 
contribute to overall blood loss in blunt trauma. This is often 
underestimated. 
- We do not possess reproducible guidelines of why and how blood 
component transfusion is initiated in the first 24 hrs in major trauma. 
- The changes that occur in the availability of blood components by 
implementing a MTP, in the clinically most relevant first 6 hrs after 
injury, is largely unknown. 
Thus, our clinical investigations were undertaken with three main aims in 
mind: 
1. To establish the contribution of orthopaedic injuries to overall blood 
component consumption in the first 24 hrs after injury. We 
hypothesised that orthopaedic injuries are major contributors to 
acute blood product usage. 
2. To describe the pattern and triggers of acute transfusions. We 
hypothesised that acute transfusions after trauma are indicated on 
objective parameters. 
3. To examine the effect of a MTP on balanced component delivery in 
the first 6 hrs in massively transfused patients. We hypothesised that 
the implementation of a MTP accelerates the delivery of blood 
components, especially in the first 6 hrs after injury. 
 
CLINICAL STUDIES: 
Two separate clinical studies were performed. All cases involved in the 
clinical investigations were patients of the John Hunter Hospital. The John 
Hunter Hospital is a University affiliated, Level 1 Trauma Centre. Based on 
the severely injured trauma admissions (injury severity score (ISS) > 15), it is 
the busiest trauma service in the state of New South Wales, Australia. 
 
1. Orthopaedic trauma related acute transfusions and transfusion 
triggers  
Background: 
Up to three quarters of blunt trauma patients will require at least one 
orthopaedic intervention. In the absence of significant torso injuries 
orthopaedic trauma can potentially be the sole contributor to lost blood 
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volume. The available empirical guidelines that help to estimate potential 
blood loss are unreferenced and are not validated. Studies reviewing blood 
component usage in trauma are retrospective and registry-based and fail to 
identify transfusion triggers.  
Transfusion guidelines for trauma patients relate to 
haemodynamically stable patients after initial resuscitation and haemorrhage 
control. In the ATLS (Advanced Trauma Life Support) protocol, the 
recommendation regarding early transfusion (ET) is not exact and is 
unreferenced. Attempts to verify the validity of physiological parameter 
thresholds used for classifying the bleeding patient have been unsuccessful. 
 
Material and Methods: 
A 12 month prospective observational clinical study was undertaken 
to identify consecutive trauma admissions, requiring at least one unit of 
PRBC within 24 hrs of arrival to hospital. The patients were identified 
prospectively on a daily basis by the trauma fellows and trauma surgeons 
during the daily ward round. 
Patients receiving ET were subdivided into three groups, patients 
with primarily orthopaedic injuries (musculoskeletal injuries exclusively or 
mainly explain the blood loss and transfusion requirement), patients where 
orthopaedic injuries partially contributed to blood product requirement along 
with torso injuries and patients with no orthopaedic injuries. 
Transfusion patterns and triggers were also examined for the same 
patient group. Five triggers were established prior to the study, and using 
these triggers the trauma fellow requested and recorded the reason for the 
first unit of transfusion from the initiating clinician, in real time. The 
corresponding recorded physiological parameters were collected. 
The established triggers were:  
1. institutional definition of haemorrhagic shock (systolic blood 
pressure (SBP) ≤90 mmHg and base excess (BE) ≤-6 mmol/l) 
2. expected and ongoing bleeding (prehospital blood loss and/or 
expected further blood loss intraoperatively due surgery) 
3. dropping haemoglobin (Hb) (Hb drop to below 80 g/l or below 100 
g/l and 30 g/l drop within 2hrs 
4. low SBP (persistent hypotension on serial measurements <90 
mmHg for at least 30 mins despite fluid replacement) 
5. tachycardia (persistent elevated heart rate (HR) on serial 
measurements >110 beats/min for at least 30 mins despite fluid 
replacement) 
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Collected variables in the first study included: 
Age, gender, ISS, mechanism of injury, pre-transfusion 
haemodynamic parameters (SBP, HR, BE, Hb (prior to the first unit of PRBC 
transfusion) were collected. Timing of transfusion (from admission to the 
first unit of PRBC) and place of transfusion (emergency department (ED), 
operating theatre (OT) or intensive care unit (ICU)) was recorded. The 
transfusion initiating clinician’s specialty and grade was also studied. The 
volume of the various blood components was recorded, determining the 
number of units of PRBC, fresh frozen plasma (FFP), cryoprecipitate 
(CRYO) and platelets (PLT). 
Main outcome measures were mortality (within 24hrs and overall), 
ICU admission, hospital and ICU length of stay (LOS). Emergent (within 24 
hrs) surgical procedures were noted. 
 
Results:  
A. Orthopaedic injury related transfusions 
Nine per cent (91/965) of all major trauma admissions received 
early transfusion. Seventy per cent (64/91) of these transfused patients had 
one or more orthopaedic injuries. Ten of these patients had additional 
bleeding sources identified.  The injury mechanism was predominantly blunt 
(94% (60/64)). The three early transfusion groups (only orthopaedic injuries, 
orthopaedic and torso injuries and only torso injuries) showed no differences 
in basic demographics and mortality. The overall mortality amongst patients 
with orthopaedic injuries was 13% (8/64). Five of the deaths happened within 
24 hrs. ICU LOS was significantly higher in the group with no orthopaedic 
injuries (10±10) vs. patients with only orthopaedic injuries (5±4) contributing 
to blood loss (p=0.008). Hospital LOS was significantly higher in the 
orthopaedic injury group (26±19 vs. 16±12) (p=0.023).   
Orthopaedic related injuries consumed the majority of acute 
transfusions with 80% (462/575) of PRBC, 76% (277/357) of FFP, 76% 
(399/527) of CRYO and 78% (174/222) of PLT. Forty-eight per cent (31/64) 
of patients required activation of the MTP. Two thirds of the patients had at 
least 4 units of PRBC within 24 hrs of arrival (42/64). Eighty-four per cent 
(54/64) of patients required emergent (within 24hrs) orthopaedic 
intervention, 90 acute procedures in all. 
 
The detailed blood product consumption and transfusion timing in the three 
separate groups is detailed in Table 1.  
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Table 1. MTP activation, transfusion timing and acute blood product usage in 
the three groups (only orthopaedic injuries, orthopaedic and other injuries, no 
orthopaedic injuries) 
 
Groups Orthopaedic 
injuries only 
(n=54) 
Orthopaedic 
and other 
injuries 
(n=10) 
No orthopaedic 
injuries  
(n=27) 
p-value 
MTP  50% (27/54) 40% (4/10) 30% (8/27) 0.2201 
ONeg PRBC 1.7±2.8 2.8 ±3.0 0.9±1.4 0.093 
Overall PRBC 6.6±5.4 10.8 ±11.1* 4.3±5.0* 0.001* 
FFP 4.0±4.5 6.3 ±8.1 2.9±4.1 0.174 
CRYO 5.5±6.9 10.3 ±14.7 4.7±7.8 0.180 
PLT 2.5±4.2 4.2±8.0 1.8±4.3 0.402 
1
st
 unit (hrs) 3.3±4.6 1.8±1.6 5±6 0.155 
1
st
 unit in ED 39% (21/54) 60% (6/10) 41% (11/27) 0.493 
 1
st
 unit in OT 57% (31/54) 40% (4/10) 33% (9/27) 0.107 
1
st
 unit in ICU 4% (2/54)* 0% 26% (7/27)* 0.007* 
*: significant difference (p<0.05) 
   
Orthopaedic injuries and injury combinations: 
Pelvis and acetabulum:  
Twenty-five of the patients had a pelvic or acetabular fracture or 
ligamentous pelvic ring injury injury (39% (25/64)). Twenty-two had pelvic 
ring injuries. Nine patients required surgery in the first 24 hrs. Only three of 
the patients had orthopaedic injuries isolated to the pelvic girdle. The most 
frequent additional injury combinations were femur fracture (6 patients) or 
femur and tibia fracture (6 patients). Four of the 25 patients also had a 
laparotomy. In four of the eight deaths, bleeding due to pelvic ring injury was 
a contributor. These patients had the highest ISS with a value of 39±22. 
Seventy-two per cent (18/25) were admitted to the ICU, spending an average 
of 4±4 days there.  These patients used on average 8.1±6.8 units of PRBCs, 
5.4±5.3 units of FFP. MTP activation was required in 56% (14/25) and 36% 
(9/25) of patients had more than 10 units of PRBCs.  
   
Femur fracture: 
Twenty-four (37% (24/64)) of the patients had at least one femoral 
shaft fracture and received early transfusion, two patients having bilateral 
femur fractures. Twenty-three were treated operatively within 24 hrs. Only 2 
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of the patients had orthopaedic injuries isolated to the femoral shaft. Five of 
the femur fractures were open. Patients with a femoral shaft fracture used on 
average 7.1±6.1 units of PRBCs, 4.4±5.1 units of FFP. MTP activation was 
required in 58% (14/24).   
 
Tibia fracture: 
Twenty patients had a total of 23 tibia fractures, 17 were tibial shaft 
fractures and 6 periarticular fractures. Nine patients suffered open tibia 
fractures, with three Gustillo-Andersen 3A, two 3B and four 3C fractures. 
Only 3 patients had isolated tibia shaft fractures. Ten patients had operative 
intervention within the first 24hrs.  
  
Additional orthopaedic injuries: 
Additional long bone fractures included 14 humerus fractures (nine 
treated operatively), nine forearm fractures (eight treated operatively) and 
five ankle fractures. Thirty-five patients had large open wounds requiring 
surgery. Two patients with pelvic ring injuries developed a large degloving 
injury, which necessitated surgical management. 
 
Results:  
B. Transfusion triggers and patterns 
Forty-three per cent (39/91) of ET patients had an activated MTP. 
Emergent surgery (<24 hrs) was necessary in 86 % (78/91) of patients. Forty 
seven per cent (37/78) of the patients had surgery primarily for bleeding 
control, 41 haemostatic procedures in all. Overall mortality was 14% (13/91) 
with 54% (7/13) having had a MTP activation. Thirty-eight per cent (5/13) of 
deaths happened within 24hrs, with one exsanguination related death.  
 
Timing and place of transfusion: 
ETs start within 2 hrs of arrival in 59% (54/91), with the 92% 
(36/39) of the MTP activations happening in this timeframe. The timing of 
the first transfused unit of blood differed in the various locations (ED, OT, 
ICU). Patients receiving transfusion in ED had a higher ISS, received blood 
quicker and in larger volumes, having worse physiological parameters (lower 
SBP, higher HR and lower BE). Detailed data is presented in Table 2.  
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Table 2. Place timing of first unit of transfusion. Transfusion volume, 
physiological parameters and transfusion triggers according to place of 
transfusion. 
 
Data is presented as median, range and IQR 
 
Transfusion triggers: 
The transfusion triggers used to initiate an acute transfusion varied 
in the different environments. In the ED patients were either in haemorrhagic 
shock (37%) or had ongoing or expected bleeding (23%). In the OT ongoing 
or expected bleeding (40%) or a drop in Hb (40%) was the most frequent 
triggers. In ICU 66% had a dropping Hb triggering the acute transfusion. 
 
Place of 
transfusion 
ED OT 
 
ICU Total 
Number of 
patients 
47 35 9 91 
ISS 32 (4-66, 
IQR:20-43) 
18 (4-59, 
IQR:13-29) 
25(9-45, 
IQR:20-34 
25 (4-66, IQR:16-34) 
Time to 1st 
unit 
0.5 (0.5-4, 
IQR:0.5-1.5) 
3 (1-23, IQR:2-
6) 
11(0.5-20, 
IQR:6-17) 
2(0.5-23, IQR:0.5-4) 
MTP 
activation 
64% (30/47) 23% (8/35) 11% (1/9) 43% (39/91) 
PRBC 8 (1-34, IQR:2-
10) 
3 (1-14, IQR:2-
6) 
3(1-27, IQR: 2-
3) 
4(1-34, IQR:2-8) 
SBP 85 (45-120, 
IQR:79-96) 
100(74-120, 
IQR:86-103) 
100(71-125, 
IQR:100-110) 
90(45-125, IQR:80-
100) 
HR 118 (60-163, 
IQR:87-130) 
90(53-130, 
IQR:80-100) 
90(60-145, 
IQR:70-115) 
100(53-163,IQR:80-
120) 
HB 105 (56-166, 
IQR: 92-129) 
91(50-137, 
IQR:78-111) 
88(76-108, 
IQR:82-93) 
96(50-166, IQR:85-
114) 
BE -4.7 (-22.1-2.7, 
IQR:-8.9--2.2) 
-3.7 (-9.1-0.5, 
IQR:-5.9—2.5) 
-2.6(-5.7-2.7, 
IQR:-4.5—1.5 
-4.2(-22.1-2.7, IQR:-
7.2—2.4) 
Transfusion triggers 
h. schock 37% (17/47) 14% (5/35) 0% 24% (22/91) 
exp. or ong. 
bleeding 
23% (11/47) 40% (14/35) 11% (1/9) 29% (26/91) 
dropping Hb 9% (4/47) 40% (14/35) 66% (6/9) 26% (24/91) 
low SBP 15% (7/47) 6% (2/35) 0% 10% (9/91) 
tachycardia 15% (7/47) 0% 0% 8% (7/91) 
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Indicating clinician: 
Various members of the trauma team were responsible for initiating 
the first unit of transfusion with varying frequency. The trauma surgeon 
initiated the first blood transfusion in 34% (31/91), out of those 77% (24/31) 
had MTP. 31% (28/91) were triggered by the anaesthetist, with 21% (6/28) 
being MTPs. 19% (17/91) were started by the ED doctor 41% (7/17) being 
MTPs. The remaining transfusions were ordered by the ICU doctor 12% 
(11/91) and the surgical team (3/91) with one MTP activation in each group. 
Clinicians of different specialties indicated a transfusion using 
different trigger patterns.  Most frequent trigger by specialty: trauma – 
haemorrhagic shock 45% (14/31), whilst anaesthesia and ICU – dropping Hb 
46% (13/28) and 55% (6/11) respectively. ED doctors and general surgeons 
had an even distribution of triggers. 
 
Blood product usage: 
Eighteen patients 20%(18/91) received ≥10 units of PRBC; the 
mortality of this group was 28% (5/18). Fifty patients 55%(50/91) received 
≥4 units of PRBC within 24 hrs, with 14% (7/50) mortality. The patients 
attracting MTP activation consumed the majority of blood products used by 
the trauma service, 83% (118/142) of the ONegative, 72% (413/575) of all 
PRBC, 83% (295/357) of FFP, 94% (493/527) of CRYO and 95% (210/222) 
of PLTs. MTP activation allowed early balanced component therapy with an 
FFP: PRBC ratio of 1:1.4.  
 
Overtransfusion:  
Patients were assessed for potential overtransfusion by recording 
their Hb concentrarion at ICU admission and at 24 hrs. Fifteen per cent 
(14/91) had a 24 hr Hb concentrarion of >110 g/l indicating potential 
unnecessary transfusion. The 24hr overtransfusion rate was 8% (3/39) in the 
MTP and 21% (11/52) in the non-MTP group.  There were 32 patients 35% 
(32/91) who only received 1 or 2 units of PRBC. The overtransfusion rate 
was higher in this low volume transfusion group at 25% (8/32).  
In terms of transfusion trigger, overtransfusion rate was highest with 
low SBP 22% (2/9) or expected and ongoing haemorrhage 19% (5/26) as the 
trigger.  
 
Discussion: 
Our prospective observational study found that musculoskeletal 
injuries are the main indications for blood product transfusion in the first 24 
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hrs consuming more than three quarters of all acute trauma related 
transfusions. Eighty-nine per cent (16/18) of massively transfused (>10 units 
of PRBC ≤24 hrs) patients had an orthopaedic injury. Our study provides 
prospectively collected baseline numbers of early transfusion requirements in 
orthopaedic trauma. 
Understanding why, where and by whom is transfusion initiated in 
the acute setting might help reduce the amount overall blood component 
usage. A specific pattern of ET was observed, with 90% initiated within 6 hrs 
of admission and 90% commencing either in ED or in OT. A single objective 
trigger cannot be utilised in the ET setting, and Hb concentration was only 
used as a trigger in one quarter of the cases (23/91). The real-time identified 
trigger was different amongst the various specialists as they were present at 
different stages of injury care.  
Due to the acute and dynamic nature of traumatic shock, it is 
difficult to identify ‘hard’ triggers and standardise transfusion guidelines. 
The tissue injury and the physiological derangement coupled by 
pathophysiological inflammatory responses and therapeutic confounders 
further complicate decision making for acute transfusion. Current guidelines 
recommend an intensive care and trauma transfusion trigger of 70g/l Hb 
concentration for patients without comorbidities. As demonstrated by our 
study, admission Hb concentration is unreliable in trauma, because of the 
variations in injury patterns, the duration of prehospital time, the delay in 
intrinsic compensatory fluid transfer from the extacellular space and 
haemodilution (due to crystalloid resuscitation). Hb concentration in our 
study averaged >100 g/l, and only if used as a dynamic marker, showing a 
significant drop was it used as a transfusion indicating parameter.  
Our study used five important triggers, all of which relevant to the 
acute transfusion settings. The triggers were based on relevant parameters or 
their combinations, and included SBP, HR, BE and the more conventional 
Hb concentration. Just as important, although not easily quantifiable, is the 
insight into the severity of injuries, and what procedure combinations are 
required for their treatment. 
The clinical decision making of the different specialists and trainees 
varied. The trauma surgeon was most likely indicate a transfusion because of 
haemorrhagic shock, whilst the ED doctors, anaesthetists and ICU doctors 
initiated blood transfusion mostly on the basis of a single physiological 
parameter or blood test result.  
Our MTP was an integral part of the resuscitative efforts of the first 
24 hrs. Activating it allowed for early balanced component therapy. 
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2. The effect of a massive transfusion protocol on blood 
component delivery in the first 6 hrs  
 
Background: 
In the civilian setting the development of Massive Transfusion 
Protocols (MTPs) has been central in achieving improved component ratios 
and frequently improved outcomes compared to historic cohorts.  Evidence 
on MTPs compares outcomes based on the cumulative ratios of blood 
products administered during the first 24 hours following injury. By 24 hrs, 
especially among survivors, balanced cumulative values are achieved in most 
cases, regardless of the initial resuscitation strategy.  
 
Material and Methods: 
A retrospective study was undertaken to compare the dynamics of 
blood component delivery in patients requiring massive transfusion before 
(pre-MTP) and after the implementation of the MTP. The pre-MTP period 
was 48 months before January 2005 and the MTP period was 40 months from 
January 2006. In 2005 an institutional Massive Transfusion Protocol (MTP) 
(Table 3) was developed and implemented. The ratios PRBC, FFP, PLT and 
CRYO in each pack were determined in consultation with the trauma service, 
blood bank and the haematology service. An MTP is triggered by a member 
of the trauma team when massive transfusion is needed or the anticipated 
need is 4 units of PRBC. 4 units of 0 Negative PRBCs and 4 units of AB 
positive FFP (thawed) are readily available at all times.  The massive 
transfusion packs 1 and 2 are released in an alternating sequence. After the 
delivery of the first two massive transfusion packs, continuation and adjuncts 
(rVIIa) to the massive transfusion are discussed with the on-call 
haematologists. The 12-month transitional period (development and 
implementation of MTP) between January 2005 and January 2006 was not 
considered for this study. Massive transfusion was defined as 10 or more 
units of PRBCs during the first 24 hours after admission.  
 
Table 3. Sequence of blood products included in consecutive MTP packs.   
 
MTP 1 4 units of PRBC, 4 units of FFP, 10 units of CRYO 
MTP 2 4 units of PRBC, 4 units of FFP, 1 unit of Pooled PLT 
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All trauma patients over the age of 16 years who required greater 
than or equal to 10 units of PRBCs within 24 hours were included. Patients 
were identified by blood bank receipts, and cross referenced with the trauma 
registry. General information collected on each case included demographics, 
abbreviated injury scale (AIS), injury severity score (ISS), Glasgow Coma 
Score (GCS) on admission, shock parameters on admission including systolic 
blood pressure (SBP), pH and base excess, as well as coagulation profile at 
admission (coagulopathy at admission was defined as PT >13s / APTT >35s). 
To determine ratios of blood products and the timing of their administration, 
data on what blood products were released from the blood bank and the time 
of administration were collected. The overall number of each blood 
component (PRBC, FFP, CRYO, PLT) was recorded. PRBC transfusions 
were subdivided into O Negative, O positive or cross-matched PRBCs.  
The primary outcome measures were ratios of products (FFP:PRBC, 
CRYO:PRBC and PLT:PRBC) given at each half hour during the first 24. 
Secondary outcomes included mortality (within 24 hrs and overall), time of 
death after admission (for mortality within 24 hrs and overall), the need for 
surgery within 24 hrs and ICU length of stay. 
The blood component ratios (FFP/PRBC, CRYO/PRBC and 
PLT/PRBC) for each patient were calculated on the cumulative values of 
their blood components every half hour with the total area under the curve 
(AUC) estimated using the trapezoidal rule.  
 
Results 
 The effect of implementing a MTP on early component delivery 
 
During the 88-month study period, 58 patients required 10 or more 
units of PRBCs during the first 24 hours after admission. Thirty had massive 
transfusion before the introduction of the MTP during a 48-month period and 
28 had massive transfusion during a 44-month period after. The univariate 
comparisons of demographics, mechanism of injury, injury severity and 
pattern and physiological parameters are depicted in Table 4.  The 
demographics were not different in regard to age (p=0.46) and gender 
(p=0.77). The two groups differed significantly in their respective ISS [Pre-
MTP: 36±12 vs. MTP: 42±12 (p=0.045)], and AIS head [Pre-MTP: 1.6±2.0 
vs. MTP: 2.6±1.8 (p=0.043)]. There was no difference in haematology and 
blood gas results and systolic blood pressure values preceding transfusion. 
Admission GCS was lower in the MTP group (p=0.023).  
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Table 4. Patient demographics, injury type and severity.  
 Pre-MTP (n=30) MTP (n=28) p-value 
Age (years) 46.0 ± 17.7 42.6 ± 18.8 0.477 
Gender (males) 23/30 (77%) 20/28 (71%) 0.659 
Injury (%blunt) 28/30 (93%) 25/28 (89%) 0.665 
ISS 36 ± 12* 42 ± 12* 0.045* 
AIS Head 1.6 ± 1.8* 2.6 ± 2.0* 0.043* 
GCS 11 ± 5* 8 ± 5* 0.023* 
Surgery ≤ 24 hrs 27/30 (90%) 28/28 (100%) 0.238 
*: significant difference (p<0.05) 
The area under the curve (AUC) showed that significantly earlier 
delivery of higher median ratios of FFP/PRBC (p=0.004) occurred in the 
initial 6 hours, post implementation of the MTP (Fig. 1). Median ratios of 
FFP/PRBC elevate close to maximum levels within 3 hrs. Similar findings 
were demonstrated for median CRYO/PRBC ratios (p=0.003) and 
PLT/PRBC ratios.  
 
Figure 1. 
Hourly median FFP / PRBC ratios pre-MTP and after the implementation of 
the MTP 
 
 
 
The number of transfused units of PRBC during the first 24 hours 
was almost identical in the two groups (Table 5.) There was significantly 
higher use of 0 Negative (p=0.016) and 0 Positive blood (p=0.003) after the 
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implementation of the MTP. The use of FFP has not changed (p=0.416), but 
the delivery of CRYO (p=0.009) and PLTs improved (p=0.018). There was 
no significant change in the percentage of patients achieving FFP:PRBC ratio 
of 1:2 or above 37% vs 50% (p=0.427). 
 
Table 5. Volume and ratio of blood products in the Pre-MTP and MTP 
groups.  
 Pre-MTP (n=30) MTP (n=28) p-value 
Overall PRBC 19.6 ± 9.7 19.8 ± 8.5 0.927 
0 Negative PRBC 1.6 ± 2.2* 3.4 ± 3.2* 0.016* 
0 Positive PRBC 0.8 ± 2.6* 3.8 ± 4.5 0.003* 
Cross-matched PRBC 17.2 ± 10.0  12.7 ± 7.0 0.053 
FFP 8.1 ± 6.2  9.4 ± 5.8 0.416 
Cryoprecipitate 5.4 ± 8.4*  11.6 ± 9.1* 0.009* 
PLT 5.8±6.8*  10.1 ± 6.5* 0.018* 
FFP:PRBC ratio at 6 hrs 0.36±0.27 0.48±0.27   0.101 
FFP:PRBC ratio at 24 hrs 0.40±26 0.45±24 0.372 
%  FFP: PRBC ratio of ≥1:2 37% (11/30) 50% (14/28) 0.427 
*: significant difference (p<0.05) 
Secondary outcomes showed no significant differences. Patients had 
similar mortality, mortality within 24hrs, need for emergent surgery and ICU 
length of stay. The univariate regression analysis for the MTP group revealed 
that each 1 point drop in GCS has an odds ratio of 1.3 for mortality 
(p=0.016), and each 0.1 drop in pH has an odds ratio of 2.7 for mortality 
(p=0.020).  
 
Discussion 
The aims of predefined ratios in using a massive transfusion 
protocol are optimisation of the ratios of blood products used. MTPs have 
also been associated with decreased overall blood product use, reducing the 
risk of a secondary hit of resuscitation. There are institutional variances 
regarding massive transfusion pack contents, their sequence and the optimum 
ratios of components that are to be achieved. Higher FFP: PRBC ratio is an 
independent predictor of survival.  
The ideal ratio in providing balanced component therapy remains 
unknown, as demonstrated in a recent review examining the current available 
evidence supporting the often recommended FFP:PRBC ratio of 1:1. 
Although the evidence is not compelling, and survival bias still needs to be 
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addressed, it seems a reasonable strategy to strive for a ratio of FFP:PRBC of 
at least 1:2. In our study both pre-MTP and MTP 24 hour FFP: PRBC ratios 
were in this range, with figures of 1:2.5 and 1:2.2 respectively (p=0.370). 
Mean FFP: PRBC ratios at 6 hours were 1:2.8 in the pre-MTP group and 
1:2.1 in the MTP group (p=0.010). 
Our study raises questions about using 24 hour cumulative ratios to 
describe blood component therapy outcomes. By 24 hrs patients either 
exsanguinate if haemorrhage control is unsuccessful or if surviving, blood 
component therapy catches up with PRBC transfusion.  We demonstrated 
significant differences in the delivery of FFP:PRBC, CRYO:PRBC and 
PLT:PRBC ratios at 6 hours following implementation of the MTP. 
 
CONCLUSIONS 
To summarize our hypotheses can be answered as follows:  
1. Musculo-skeletal injuries are the leading cause for early transfusion 
after blunt trauma, and consume more than 75% of all blood 
components used in the first 24 hrs. These injuries required an 
average of 7.2±6.6 units of PRBCs and 4.3±5.2 units FFP, with 48% 
(31/64) requiring MTP activation. The awareness and anticipation of 
such major blood loss should prompt to utilise the MTP and focus 
on procedures, which aim haemorrhage control and limit further 
surgery related blood loss. It is an important message for trauma 
centres primarily dealing with blunt multi-system trauma that most 
of the blood transfusions are related to extremity and pelvic injuries 
rather than thoracic and abdominal trauma.  
2. We also clarified the 5 most relevant transfusion triggers in major 
trauma patients that were used during the first 24 hours. A statically 
measured haemoglobin concentration is insufficient as a trigger in 
the trauma setting. Although all 91 ET patients had a definable 
trigger, arguably only 50% (46/91) (haemorrhagic shock and 
dropping Hb) could be called objective. Liberal transfusions 
(expected and/or ongoing bleeding, low SBP and tachycardia) based 
on vital signs, blood gas results, and experience based anticipated 
bleeding requires a larger scale investigation to better define their 
clinical role. The overtransfusion rate is higher with these more 
liberal transfusions. These triggers might not be evidence based or 
backed up by latest laboratory science, but they demonstrate how 
human decision making actually works in these challenging clinical 
scenarios. These results could serve base for standardising 
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transfusions during acute resuscitation, similar to how transfusions 
are regulated in the elective setting or in critical care medicine. 
3. The evaluation of our massive transfusion practice revealed that the 
implementation of MTP results in earlier balanced transfusion. The 
difference between the FFP/PRBC ratios of the traditional 
resuscitations methods and an MTP assisted strategy is no longer 
relevant by 24 hours. Based on our research the efficacy of 
component therapy delivery is best described by blood component 
ratios achieved in the first 6 hours. This more relevant time frame 
should be used in future studies, when evaluating the efficacy of 
MTP and haemostatic resuscitation with different plasma to red 
blood cell ratios, which is the current priority focus for many 
leading trauma institutions and their collaborative efforts. 
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